Psychemedics Corporation: Business Overview, Financials & Competitive Analysis
Psychemedics Corporation scores 6/10 on the AskCyborg Cyborg Score (Solid). Market-leading niche player with strong competitive moat, transitioning to private status while maintaining innovation momentum through emerging threat detection (ketamine, synthetic cannabinoids). Psychemedics is the globally recognized leader in hair drug testing with a dominant position among Fortune 500 companies, law enforcement agencies, and educational institutions. However, the company's transition.
What is Psychemedics Corporation's industry? Psychemedics Corporation (psychemedics.com) operates in Drug Testing & Workplace Wellness Services. AskCyborg classifies Psychemedics Corporation under Drug Testing & Workplace Wellness Services in its company registry.
Psychemedics Corporation is a global provider of hair testing for drugs of abuse. The company focuses on using hair samples to detect drug use over extended periods, offering a long detection window, resistance to eva...
Cyborg Score thesis
Market-leading niche player with strong competitive moat, transitioning to private status while maintaining innovation momentum...
Read the full analyst-debate transcript →Get the Latest Psychemedics Corporation Report
Up-to-date AI-powered research, analyst debate audio & saved-company playlists
Get Current Report FreePsychemedics Corporation Overview
Pro stress-test →Psychemedics Corporation is a global provider of hair testing for drugs of abuse. The company focuses on using hair samples to detect drug use over extended periods, offering a long detection window, resistance to evasion, and detailed insight into substance use patterns. Psychemedics pioneered the use of hair drug testing and remains by far the largest and leading supplier of drugs of abuse hair testing worldwide.
Strategic Profile
Pro stress-test →The company serves employers across industries including petrochemical, transportation, manufacturing, retail, hospitality, gaming, and education; law enforcement agencies; rehabilitation programs; and public entities such as Federal Reserve banks and schools worldwide. The company executed a 1-for-5000 reverse stock split followed by a 5000-for-1 forward stock split effective December 3, 2024, to facilitate delisting from the Nasdaq Capital Market and reduce annual compliance costs exceeding $845,000.
Competitive Landscape
Pro stress-test →Psychemedics operates in a highly specialized market with limited direct competitors. The company's proprietary hair extraction technology and 40-year history create significant barriers to entry. Traditional competitors in drug testing include urine and saliva-based providers, but Psychemedics' longer detection window and court-admissible results provide distinct advantages for workplace safety-sensitive environments.
Industry Context
Psychemedics Corporation operates in Drug Testing & Workplace Wellness Services.
Key facts
Founded: 1986 · Headquarters: Dallas, Texas